Genetic variation increases risk of metabolic side effects in children on some antipsychotics

25th January, 2012 - Posted by admin -


Researchers have found a genetic variation predisposing children to six-times greater risk of developing metabolic syndrome when taking second-generation anti-psychotic medications. Metabolic syndrome is a cluster of conditions that are risk factors for cardiovascular disease. The study showed a close association with two conditions in particular: high blood pressure and elevated fasting blood sugar levels, which is a precursor to diabetes.

Posted on: January 25, 2012

Filed under: Asperger Syndome, Autism

No Comments

No Comments

Leave a reply